Watch for Confusion Between Fiasp and NovoLog

Reps will promote the new insulin aspart (Fiasp, FEE-asp) as an "ultrafast-acting" mealtime insulin for adults....

Get unlimited access through an Enterprise license

Hospital Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals